Does Diabetes Increase the Risk of Contracting COVID-19? A Population-Based Study in Korea|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Background This study aimed to determine the infection risk of coronavirus disease 2019 (COVID-19) in patients with diabetes (according to treatment method).
Methods Claimed subjects to the Korean National Health Insurance claims database diagnosed with COVID-19 were included. Ten thousand sixty-nine patients with COVID-19 between January 28 and April 5, 2020, were included. Stratified random sampling of 1:5 was used to select the control group of COVID-19 patients. In total 50,587 subjects were selected as the control group. After deleting the missing values, 60,656 subjects were included.
Results Adjusted odds ratio (OR) indicated that diabetic insulin users had a higher risk of COVID-19 than subjects without diabetes (OR, 1.25; 95% confidence interval [CI], 1.03 to 1.53; P=0.0278). In the subgroup analysis, infection risk was higher among diabetes male insulin users (OR, 1.42; 95% CI, 1.07 to 1.89), those between 40 and 59 years (OR, 1.66; 95% CI, 1.13 to 2.44). The infection risk was higher in diabetic insulin users with 2 to 4 years of morbidity (OR, 1.744; 95% CI, 1.003 to 3.044).
Conclusion Some diabetic patients with certain conditions would be associated with a higher risk of acquiring COVID-19, highlighting their need for special attention. Efforts are warranted to ensure that diabetic patients have minimal exposure to the virus. It is important to establish proactive care and screening tests for diabetic patients suspected with COVID-19 for timely disease diagnosis and management.

번역하기

참고문헌 (Reference)

1 Ko SH, "Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: nationwide population-based cohort study" 95 : e4018-, 2016

2 Harding JL, "Trends in rates of infections requiring hospitalization among adults with versus without diabetes in the U. S., 2000-2015" 43 : 106-116, 2020

3 Mancuso P, "The role of adipokines in chronic inflammation" 5 : 47-56, 2016

4 Vijayanand P, "Severe acute respiratory syndrome (SARS): a review" 4 : 152-160, 2004

5 Carey IM, "Risk of infection in type 1 and type 2 diabetes compared with the general population : a matched cohort study" 41 : 513-521, 2018

6 World Health Organization, "Report of the WHO-China Joint Mission on Coronavirus Disease 2019(COVID-19)" World Health Organization 1-40, 2020

7 Badawi A, "Prevalence of diabetes in the 2009 influenza A(H1N1)and the Middle East respiratory syndrome coronavirus : a systematic review and meta-analysis" 5 : 733-, 2016

8 Badawi A, "Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus(MERS-CoV) : a systematic review and meta-analysis" 49 : 129-133, 2016

9 Yang J, "Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2 : a systematic review and meta-analysis" 94 : 91-95, 2020

10 Patel JA, "Poverty, inequality and COVID-19 : the forgotten vulnerable" 183 : 110-111, 2020